Vaccine pricing strategies in China

Haonan Zhang^{1

2}, Bryan Patenaude^{3

4}, Chao Ma⁵, Hai Fang^{6

7}

Affiliations

¹ China Center for Health Development Studies, Peking University, Beijing, China.
² Department of Health Policy and Management, Schoolf of Public Health, Peking University, Beijing, China.
³ Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁴ International Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
⁵ National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
⁶ China Center for Health Development Studies, Peking University, Beijing, China hfang@hsc.pku.edu.cn.
⁷ Peking University Health Science Center - Chinese Center for Disease Control and Prevention Joint Research Center for Vaccine Economics, Peking University, Beijing, China.

PMID: 37402511
PMCID: PMC10335538
DOI: 10.1136/bmjgh-2022-011405

Vaccine pricing strategies in China

Haonan Zhang et al. BMJ Glob Health. 2023 Jul.

. 2023 Jul;8(7):e011405.

doi: 10.1136/bmjgh-2022-011405.

Authors

Haonan Zhang^{1

2}, Bryan Patenaude^{3

4}, Chao Ma⁵, Hai Fang^{6

7}

Affiliations

¹ China Center for Health Development Studies, Peking University, Beijing, China.
² Department of Health Policy and Management, Schoolf of Public Health, Peking University, Beijing, China.
³ Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁴ International Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
⁵ National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
⁶ China Center for Health Development Studies, Peking University, Beijing, China hfang@hsc.pku.edu.cn.
⁷ Peking University Health Science Center - Chinese Center for Disease Control and Prevention Joint Research Center for Vaccine Economics, Peking University, Beijing, China.

PMID: 37402511
PMCID: PMC10335538
DOI: 10.1136/bmjgh-2022-011405

No abstract available

Keywords: Health economics; Health policy; Vaccines.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Cited by

The equity road ahead for financing non-national immunization program vaccines in China: challenges and opportunities from a qualitative study.
Jiang M, Jiang W, Yan X, Ma H, Zhou S, Ying X. Jiang M, et al. Int J Equity Health. 2024 Sep 27;23(1):193. doi: 10.1186/s12939-024-02282-5. Int J Equity Health. 2024. PMID: 39334358 Free PMC article.
Service delivery costs of vaccination at health facilities in Guangzhou, China.
Zhang C, Liu Z, Huang Y, Zheng Z, Wang W, Zhang Z. Zhang C, et al. Hum Vaccin Immunother. 2025 Dec;21(1):2545031. doi: 10.1080/21645515.2025.2545031. Epub 2025 Aug 18. Hum Vaccin Immunother. 2025. PMID: 40820686 Free PMC article.
Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and priorities.
Zhang H, Lai X, Patenaude BN, Jit M, Fang H. Zhang H, et al. Lancet Public Health. 2023 Dec;8(12):e1016-e1024. doi: 10.1016/S2468-2667(23)00248-7. Lancet Public Health. 2023. PMID: 38000881 Free PMC article. Review.
Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review.
Wong LP, Lee HY, Alias H, Zimet G, Liu T, Lin Y, Hu Z. Wong LP, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2313860. doi: 10.1080/21645515.2024.2313860. Epub 2024 Feb 15. Hum Vaccin Immunother. 2024. PMID: 38359815 Free PMC article. Review.
Public Preference and Priorities for Including Vaccines in China's National Immunization Program: Discrete Choice Experiment.
Zhang L, Li X, Chen J, Wang X, Sun Y. Zhang L, et al. JMIR Public Health Surveill. 2024 Nov 14;10:e57798. doi: 10.2196/57798. JMIR Public Health Surveill. 2024. PMID: 39588749 Free PMC article.

References

1. Ghosh PK. Human vaccines industry in China, 2019: part—I. MGM J Med Sci 2020;7:35. 10.4103/mgmj.MGMJ_27_20 - DOI
1. Vaccine market size in China 2016-2025. 2022. Available: https://www.statista.com/statistics/979820/china-vaccine-market-size
1. Vaccine administration law of the people’s Republic of China; 2019.
1. Ma C, Li J, Wang N, et al. . Prioritization of vaccines for inclusion into China’s expanded program on immunization: evidence from experts’ knowledge and opinions. Vaccines (Basel) 2022;10:1010. 10.3390/vaccines10071010 - DOI - PMC - PubMed
1. Fang H, Chen C, Fang Y, et al. . A guideline for economic evaluations of vaccines and immunization programs in China. Hum Vaccin Immunother 2022;18:2132802. 10.1080/21645515.2022.2132802 - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Vaccine pricing strategies in China

Affiliations

Vaccine pricing strategies in China

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical